ARCHIVES

Guest Editorial: Myriad Ruling Becomes a Textbook Case Of How Not To Manage a Patent Portfolio, by Robert Cook-Deegan

This article is from The Cancer Letter archive.

Vol. 39 No. 24 | June 14, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

May 11, 2007

Competition For Center Grants Higher In FY95, Kimes Tells BSC

November 25, 1994

Researchers Link Cancer Risk And DMPA Birth Control Use

April 27, 2012

Administration Seeks Authorization Bill Repealing National Cancer Act, Other NIH Special Authorities

March 8, 1985

NCI Prepares For Intramural Program Review

June 27, 2014

Spending Freeze Could Harm Medical Research, ACS Advocacy Affiliate Says

January 29, 2010